文献速递糖尿病肥胖与代谢综合征

循环细胞外囊泡携带的PTP1B和PP2A磷酸酶作为胰岛素抵抗的调节因子

Circulating extracellular vesicle-carried PTP1B and PP2A phosphatases as regulators of insulin resistance.
PubMed 文献 · Diabetologia · 2024-10-18

研究从胰岛素抵抗(IR)和非胰岛素抵抗(n-IR)个体分离循环大细胞外囊泡(lEVs)和小细胞外囊泡(sEVs),静脉注射给小鼠后分析胰岛素信号。IR来源的lEVs和sEVs损害小鼠全身、脂肪组织和肝脏胰岛素信号并增大脂肪细胞,而n-IR来源的EVs无此效应。IR lEVs富含活性PTP1B,IR sEVs主要携带活性PP2A,抑制这些磷酸酶可恢复脂肪细胞和肝细胞的胰岛素信号。

要点

  • IR个体来源的lEVs和sEVs损害小鼠全身、脂肪组织和肝脏胰岛素信号。
  • IR lEVs富含活性PTP1B,IR sEVs主要携带活性PP2A。
  • 抑制EV携带的PTP1B或PP2A可恢复脂肪细胞和肝细胞的胰岛素信号。

核心结论

  • 抑制IR个体EVs携带的磷酸酶可挽救脂肪细胞和肝细胞的胰岛素信号,提示IR EVs携带的PTP1B和PP2A是抗脂肪组织和肝脏胰岛素抵抗及肥胖发展的新潜在治疗靶点。

研究设计与样本

  • 研究分离并表征了胰岛素抵抗个体(IR组)和无胰岛素抵抗个体(n-IR组)的循环大细胞外囊泡(lEVs)和小细胞外囊泡(sEVs)。
  • 将lEVs和sEVs经静脉注射给小鼠,分析全身、脂肪组织和肝脏胰岛素信号。
  • 在靶组织和细胞中分析磷酸酶的作用。

主要发现

  • 注射IR参与者的lEVs和sEVs损害小鼠全身、脂肪组织和肝脏胰岛素信号,而n-IR参与者的EVs无影响。
  • IR参与者的lEVs和sEVs使脂肪细胞大小和成脂基因表达增加两倍。
  • IR参与者的EVs表达PTP1B和PP2A两种磷酸酶,IR lEVs富含活性形式的PTP1B,而IR sEVs主要携带活性PP2A。
  • 在IR lEVs中阻断PTP1B活性完全恢复脂肪细胞中IRS1和Akt磷酸化,并通过抑制巨噬细胞分泌组减弱肝细胞中胰岛素诱导的Akt磷酸化。
  • 在IR sEVs中阻断PP2A活性完全预防脂肪细胞和肝细胞的胰岛素抵抗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Metabolic disorders associated with abdominal obesity, dyslipidaemia, arterial hypertension and hyperglycaemia are risk factors for the development of insulin resistance. Extracellular vesicles (EVs) may play an important role in the regulation of metabolic signalling pathways in insulin resistance and associated complications. METHODS: Circulating large EVs (lEVs) and small EVs (sEVs) from individuals with (IR group) and without insulin resistance (n-IR group) were isolated and characterised. lEVs and sEVs were administered by i.v. injection to mice and systemic, adipose tissue and liver insulin signalling were analysed. The role of phosphatases was analysed in target tissues and cells. RESULTS: Injection of lEVs and sEVs from IR participants impaired systemic, adipose tissue and liver insulin signalling in mice, while EVs from n-IR participants had no effect. Moreover, lEVs and sEVs from IR participants brought about a twofold increase in adipocyte size and adipogenic gene expression. EVs from IR participants expressed two types of phosphatases, phosphotyrosine 1 phosphatase (PTP1B) and protein phosphatase 2 (PP2A), IR lEVs being enriched with the active form of PTP1B while IR sEVs mainly carried active PP2A. Blockade of PTP1B activity in IR lEVs fully restored IRS1 and Akt phosphorylation in adipocytes and blunted insulin-induced Akt phosphorylation by inhibition of the macrophage secretome in hepatocytes. Conversely, blockade of PP2A activity in IR sEVs completely prevented insulin resistance in adipocytes and hepatocytes. CONCLUSIONS/INTERPRETATION: These data demonstrate that inhibition of phosphatases carried by EVs from IR participants rescues insulin signalling in adipocytes and hepatocytes and point towards PTP1B and PP2A carried by IR EVs as being novel potential therapeutic targets against insulin resistance in adipose tissue and liver and the development of obesity.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ali S, Vidal-Gómez X, Piquet M, et al. Circulating extracellular vesicle-carried PTP1B and PP2A phosphatases as regulators of insulin resistance. Diabetologia. 2024. PMID: 39422717. doi:10.1007/s00125-024-06288-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。